Abstract:Kashin-Beck disease (KBD) is a disabling osteoarthropathy involving growth cartilage endemic to selenium (Se)-deficient regions in China. Associations between genetic variation in selenoprotein genes and susceptibility to many diseases have recently been investigated but few studies have been performed on KBD. We found four genetic polymorphisms in selenoprotein genes and assessed their association with increased susceptibility to KBD.Four polymorphisms including GPX1 (rs1050450), TrxR2 (rs5748469), SEPP1 (rs7579) and DIO2 (rs225014) were analyzed for 161 KBD patients and 312 controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or tetra-primer amplification refractory mutation system PCR (Tetra-primer ARMS PCR). Glutathione peroxidase (GPX) activity in whole blood was measured using a GPX assay kit. The mRNA expression of GPX1, nuclear factor-kappaB (NF-kappaB) p65 and p53 in both whole blood and articular cartilage tissue were detected using Real-Time PCR.The genotypic and allelic frequency of GPX1 Pro198Leu was significantly different between KBD patients and controls (P=0.013, P=0.037). A significant increased KBD risk was observed in individuals with Pro/Leu or Leu/Leu (odds ratio=1.781; 95% confidence interval: 1.127-2.814) compared with Pro/Pro. No association was observed between the other three single nucleotide polymorphisms (SNPs) and KBD risk. In addition, GPX enzyme activity in whole blood was lower in the KBD group (P<0.01), and the GPX activity in whole blood decreased significantly in a subgroup of individuals representing Pro/Leu and Leu/Leu compared to Pro/Pro (P<0.01). In whole blood and articular cartilage tissue samples of KBD patients, GPX1 and NF-kappaB p65 mRNA levels were lower (P<0.01) while p53 levels were higher (P<0.001).GPX1 Pro198Leu is a potential genetic risk factor in the development of KBD and the GPX1 Leu allele is significantly associated with higher KBD risk among the Chinese Han population and with lower GPX enzyme activity. The expression of apoptosis related molecules in KBD patients significantly differs from controls.

Role of Selenoprotein S (SEPS1) -105G>A Polymorphisms and PI3K/Akt Signaling Pathway in Kashin-Beck Disease

Selenoprotein P Gene R25191g/a Polymorphism and Quantification of Selenoprotein P Mrna Level in Patients with Kashin-Beck Disease.

Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck disease

Dysregulation of Transcription Profile of Selenoprotein in Patients with Kashin-Beck Disease and Its Effect on Se Deficiency–Induced Chondrocyte Apoptosis

Meta-analysis of Association Studies of Selenoprotein Gene Polymorphism and Kashin-Beck Disease: an Updated Systematic Review

The Roles of the Interaction of BCL2-Antagonist/Killer 1, Apoptotic Peptidase Activating Factor 1 and Selenium in the Pathogenesis of Kashin–Beck Disease

Genetic Variants and Protein Alterations of Selenium- and T-2 Toxin-Responsive Genes Are Associated with Chondrocytic Damage in Endemic Osteoarthropathy

Downregulated Expression and Hypermethylation of SIRT1 in Patients with Kashin-Beck Disease-Mediated Chondrocyte Apoptosis May Potentially Be Ameliorated by Selenium Supplement

Study On Mechanism Of Type 2 Deiodinase Gene And Erk Signal Transduction In Kashin-Beck Disease

Detection of Selenoprotein Transcriptome in Chondrocytes of Patients with Kashin–Beck Disease

The Study on Polymorphisms of Sep15 and TrxR2 and the Expression of AP-1 Signaling Pathway in Kashin-Beck Disease

The Importance of Se-Related Genes in the Chondrocyte of Kashin–Beck Disease Revealed by Whole Genomic Microarray and Network Analysis

The Role of Selenium-Mediated Notch/Hes1 Signaling Pathway in Kashin–Beck Disease Patients and Cartilage Injury Models

The Integrative Analysis of DNA Methylation and Mrna Expression Profiles Confirmed the Role of Selenocompound Metabolism Pathway in Kashin-Beck Disease.

FGF8 and FGFR3 Are Up-Regulated in Hypertrophic Chondrocytes: Association with Chondrocyte Death in Deep Zone of Kashin-Beck Disease.

The Expression of ERK and JNK in Patients with an Endemic Osteochondropathy, Kashin-Beck Disease

The Roles of Selenium, Insulin-Like Growth Factor Binding Protein 2 and Suppressor of Cytokine Signaling 3 in the Pathogenesis of Kashin–Beck Disease

Low selenium and T-2 toxin may be involved in the pathogenesis of Kashin-Beck disease by affecting AMPK/mTOR/ULK1 pathway mediated autophagy

SNP and Mrna Expression for Glutathione Peroxidase 4 in Kashin-Beck Disease

Expression Profiles of Genes Involved in Apoptosis and Selenium Metabolism in Articular Cartilage of Patients with Kashin-Beck Osteoarthritis.

Effects of selenium and iodine on Kashin-Beck disease: an updated review